CA2506356A1 - Procedes de therapie et de diagnostic - Google Patents

Procedes de therapie et de diagnostic Download PDF

Info

Publication number
CA2506356A1
CA2506356A1 CA002506356A CA2506356A CA2506356A1 CA 2506356 A1 CA2506356 A1 CA 2506356A1 CA 002506356 A CA002506356 A CA 002506356A CA 2506356 A CA2506356 A CA 2506356A CA 2506356 A1 CA2506356 A1 CA 2506356A1
Authority
CA
Canada
Prior art keywords
leukemia
tlr10
acute
cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002506356A
Other languages
English (en)
Inventor
Douglas Dedera
Peter C. R. Emtage
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nuvelo Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/302,444 external-priority patent/US20040022786A1/en
Priority claimed from US10/327,491 external-priority patent/US20040023870A1/en
Application filed by Individual filed Critical Individual
Publication of CA2506356A1 publication Critical patent/CA2506356A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne une thérapie de ciblage utilisant des polypeptides TLR10, des acides nucléiques codant pour des polypeptides TLR10, des anticorps anti-TLR10, qui fournit un procédé qui élimine ou qui inhibe la croissance de cellules cancéreuses exprimant la protéine TLR10. L'invention concerne des procédés de thérapie et de diagnostic de troubles liés aux cellules exprimant la protéine TLR10.
CA002506356A 2002-11-22 2003-11-19 Procedes de therapie et de diagnostic Abandoned CA2506356A1 (fr)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US10/302,444 US20040022786A1 (en) 2000-01-21 2002-11-22 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
US10/302,444 2002-11-22
US10/327,491 US20040023870A1 (en) 2000-01-21 2002-12-19 Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
US10/327,491 2002-12-19
US64122203A 2003-08-13 2003-08-13
US10/641,222 2003-08-13
PCT/US2003/036971 WO2004047612A2 (fr) 2002-11-22 2003-11-19 Procédés de thérapie et de diagnostic

Publications (1)

Publication Number Publication Date
CA2506356A1 true CA2506356A1 (fr) 2004-06-10

Family

ID=32397926

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002506356A Abandoned CA2506356A1 (fr) 2002-11-22 2003-11-19 Procedes de therapie et de diagnostic

Country Status (4)

Country Link
EP (1) EP1567863A4 (fr)
AU (1) AU2003295649A1 (fr)
CA (1) CA2506356A1 (fr)
WO (1) WO2004047612A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2394596C2 (ru) 2004-07-09 2010-07-20 Байер Шеринг Фарма Акциенгезельшафт Комбинированная терапия радиоактивно меченым антителом анти-cd20 при лечении в-клеточной лимфомы
AU2005269733B2 (en) * 2004-07-20 2008-10-30 Schering Corporation Induction of apoptosis in Toll-like receptor expressing tumor cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69838888T2 (de) * 1997-10-17 2008-12-11 Genentech, Inc., South San Francisco Menschliche Toll-Homologe

Also Published As

Publication number Publication date
AU2003295649A1 (en) 2004-06-18
WO2004047612A3 (fr) 2005-04-14
EP1567863A4 (fr) 2007-10-03
WO2004047612A2 (fr) 2004-06-10
EP1567863A2 (fr) 2005-08-31

Similar Documents

Publication Publication Date Title
US20040023870A1 (en) Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
US20050281813A1 (en) Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
US7378253B2 (en) Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
US20030215453A1 (en) Methods of therapy and diagnosis using immunotargeting of cells expressing VpreB1 protein
WO2005079490A2 (fr) Procedes de therapie et de diagnostic reposant sur le ciblage de cellules qui expriment les polypeptides steap2
US20090081209A1 (en) Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins
US20090220416A1 (en) Immunoglobulin associated cell-surface determinants in the treatment of b-cell disorders
US20050095237A1 (en) Methods of therapy and diagnosis using targeting of cells that express P2Y10
AU2003302733A1 (en) Methods of therapy and diagnosis using targeting of cells that express LAX
WO2004049917A2 (fr) Procedes de therapie et de diagnostic utilisant le ciblage de cellules d'expression de ly-9
CA2506356A1 (fr) Procedes de therapie et de diagnostic
CA2476555A1 (fr) Methodes therapeutiques et diagnostiques
AU2003213064B2 (en) Methods of therapy and diagnosis
US20050129697A1 (en) Methods of therapy and diagnosis using targeting of cells that express BCLP polypeptides
US20040022786A1 (en) Methods of therapy and diagnosis using targeting of cells that express toll-like receptor proteins
WO2004094607A2 (fr) Methodes de therapie et de diagnostic utilisant le ciblage de cellules qui expriment une proteine du type transporteur humaine
AU2007234602A1 (en) Methods of therapy and diagnosis
US20040109862A1 (en) Methods of therapy and diagnosis using targeting of cells that express Ly-9
JP2007512836A (ja) キラー細胞免疫グロブリン様レセプター様タンパク質を発現する細胞の標的化を用いる治療および診断の方法

Legal Events

Date Code Title Description
FZDE Discontinued